SCA-11839-90060
3 vaccinations
0 coded responses
28 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 944 / CA
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-26
Registered in v-safe
-
2021-03-26
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-26
-
2021-03-27
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-03-30
- 2021-04-04
- 2021-04-09
- 2021-04-18
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-06-25
- 2021-09-24
-
2021-12-03
Dose 2 — Moderna
-
2021-12-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-12-06
- 2021-12-09
- 2021-12-10
- 2021-12-19
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-01-14
- 2022-03-04
-
2022-04-05
Dose 3 — Pfizer-BioNTech
- 2022-05-03
- 2022-05-10
- 2022-05-17
- 2022-07-05
- 2022-10-06
- 2023-04-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-03 | Moderna | No |
| 3 | 2022-04-05 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.